Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

PHASE1

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

BIOLOGICAL: Unadjuvanted Influenza A (H7N9) Monovalent Vaccine Injection
COMBINATION_PRODUCT: Unadjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA)
COMBINATION_PRODUCT: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA)
BIOLOGICAL: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Injection
COMBINATION_PRODUCT: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA, low dose adjuvant)
COMBINATION_PRODUCT: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (low dose HA, high dose adjuvant)
COMBINATION_PRODUCT: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA, low dose adjuvant)
COMBINATION_PRODUCT: Adjuvanted Influenza A (H7N9) Monovalent Vaccine Microarray Patch Delivery System (high dose HA, high dose adjuvant)
DEVICE: Microarray Patch Delivery System

Vaxxas Pty Ltd